Cancer Institute A national cancer institute
designated cancer center

Russell K Pachynski, MD

Publication Details

  • Prostate specific antigen doubling time (PSADT) in patients with hormone refractory prostate cancer (HRPC) undergoing docetaxel chemotherapy as a predictor of overall survival. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Pachynski RK, King C, Srinivas S 2007; 25 (18s): 15556

Stanford Medicine Resources:

Footer Links: